Paper
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Published Mar 1, 2010 · D. Isaacman, E. McIntosh, R. Reinert
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Q1 SJR score
331
Citations
15
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Systematic Review
Rigorous Journal
Highly CitedStudy Snapshot
The 7-valent pneumococcal conjugate vaccine (PCV7) has led to a decline in invasive pneumococcal disease in children aged 2 years, with serotypes 1, 19A, 3, 6A, and 7F being the most common, highlighting the need for future vaccine formulation
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
PCV13 is a well-tolerated and immunogenic vaccine for infants, with most developing antibodies to all 13 serotypes and opsonophagocytic responses.
2010·181citations·K. Bryant et al.·Pediatrics
Pediatrics
27th Annual Meeting of the European Society for Paediatric Infectious Diseases
Effective common-sense preventive measures like hand hygiene can help decrease the incidence and spread of drug-resistant organisms in children.
2009·36citations·Rolando Ulloa-Gutierrez et al.·Expert Review of Anti-infective Therapy
Expert Review of Anti-infective Therapy
Differential effects of pneumococcal vaccines against serotypes 6A and 6C.
PCV7 introduction has led to reductions in serotype 6A invasive pneumococcal disease in the United States, but not serotype 6C IPD.
2008·160citations·I. H. Park et al.·The Journal of infectious diseases
The Journal of infectious diseases
Invasive pneumococcal disease in Danish children, 1996–2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine
Invasive pneumococcal disease in Danish children aged 16 years was prevalent before the introduction of the heptavalent pneumococcal conjugate vaccine (PCV7) in 2007.
2008·9citations·T. N. Winther et al.·Acta Pædiatrica
Acta Pædiatrica
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
PCV7 use in Portugal has reduced invasive infections caused by vaccine serotypes 4, 6B, 14 and 23F, but not overall resistant pneumococci.
2008·81citations·S. Aguiar et al.·Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Citations
Global distribution and characteristics of pneumococcal serotypes in adults
Pneumococcal conjugate vaccines have significantly reduced invasive pneumococcal diseases in adults, but diseases caused by non-PCV13 serotypes have increased, with regional variations in serotype distribution.
2025·0citations·H. Maeda et al.·Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics
Prevalence of Streptococcus pneumoniae serotypes causing pneumococcal diseases in the Chinese Mainland: A systematic review and meta-analysis
The top 10 prevalent Streptococcus pneumoniae serotypes causing pneumonia in the Chinese Mainland from 1997 to 2023 were 19F, 19A, 6, 23F, 14, 6B, 6A, 3, 15B, and 9 V.
2024·0citations·J. Che et al.·Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics
Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis
Nasopharyngeal pneumococcal carriage is prevalent in Latin America and the Caribbean, with a decreasing trend in serotype prevalence and replacement after the introduction of pneumococcal vaccine conjugate.
2024·1citation·Martín Brizuela et al.·PLOS ONE
PLOS ONE
Convergent impact of vaccination and antibiotic pressures on pneumococcal populations.
Vaccine and antibiotic pressures interact to alter pneumococcal population structure, impacting antibiotic resistance and capsule switching, requiring further research for public health.
2023·4citations·Cydney N. Johnson et al.·Cell chemical biology
Cell chemical biology
Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies.
Vaccinating older adults with higher-valency PCVs, particularly PCV20, could significantly reduce the remaining invasive pneumococcal disease burden in high-income countries, regardless of current pediatric and adult vaccination policies.
2023·7citations·L. Grant et al.·Vaccine
Vaccine
The Burden of Streptococcus pneumoniae-Related Admissions and In-Hospital Mortality: A Retrospective Observational Study between the Years 2015 and 2022 from a Southern Italian Province
Streptococcus pneumoniae-related hospitalizations in southern Italy from 2015 to 2022 resulted in 5% of all hospitalizations, with older adults being the most affected age group, and comorbidities playing a significant role in in-hospital mortality.
2023·14citations·F. Cedrone et al.·Vaccines
Vaccines
Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study
Increasing the availability of pneumococcal conjugate vaccines is crucial to reduce the burden of pneumococcal disease among children in Thailand.
2023·3citations·W. Phongsamart et al.·IJID Regions
IJID Regions
Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
Pneumococcal vaccination in Iraq faces challenges due to war, economic crises, poor accessibility, and high vaccine costs, requiring strengthened strategies to achieve maximum benefits.
2023·6citations·A. Al-Jumaili et al.·International Journal of General Medicine
International Journal of General Medicine